Stay updated with breaking news from Trial Accelerator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year
Excessive costs cost and time to market in clinical trials could soon be eliminated thanks to the addition of a patient access store (PAS) to Phesi's trial accelerator platform.
A partnership has been formed between Phesi and Krsytelis, born out of a need to address the lack of diversity in clinical trials.
Ancora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial enrollment.
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 17th-21st October 2022 ...